期刊
EXPERIMENTAL CELL RESEARCH
卷 340, 期 2, 页码 187-192出版社
ELSEVIER INC
DOI: 10.1016/j.yexcr.2015.10.021
关键词
Liver; Lipids; Lipid droplet; Perilipin; Steatosis; Hepatitis; Obesity; Diabetes; Alcohol; NAFLD; HCV
资金
- National Institutes of Health [K08-AA021424, P01-DK049210]
- Penn Diabetes Research Center [P30-DK-50306]
- Robert Wood Johnson Foundation, Harold Amos Medical Faculty Development Award [71586]
Cytosolic lipid droplets (LDs) are present in most cell types, and consist of a core comprising neutral lipids, mainly triglycerides and sterol esters, surrounded by a monolayer of phospholipids. LDs are heterogeneous in their structure, chemical composition, and tissue distribution. LDs are coated by several proteins, including perilipins and other structural proteins, lipogenic enzymes, lipases and membrane trafficking proteins. Five proteins of the perilipin (PLIN) family (PLIN1 (perilipin), PLIN2 (adipose differentiation-related protein), PLIN3 (tail-interacting protein of 47 kDa), PLIN4 (S3-12), and PLIN5 (myocardial lipid droplet protein)), are associated with LD formation. More recently, the CIDE family of proteins, hypoxia-inducible protein 2 (HIG2), and patanin-like phospholipase domain-containing 3 (PNPLA3) have also gained attention in hepatic LD biology. Evidence suggests that LD proteins are involved in the pathophysiology of fatty liver diseases characterized by excessive lipid accumulation in hepatocytes. This review article will focus on how hepatic LDs and their associated proteins are involved in the pathogenesis of three chronic liver conditions: hepatitis C virus infection, non-alcoholic fatty liver disease, and alcoholic liver disease. (C) 2015 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据